AgingResearch.NewsJoin free

miR-21A-5P agomir

miR-21A-5P agomir has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Oct 23, 2026: “Packages from immature bone-forming cells reduced bone loss in mice”.

Intervention

1 paper studies it1 findingUpdated

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Animals1

What did studies of miR-21A-5P agomir find?

1

Studies of miR-21A-5P agomir measured 1 outcome; the most studied are bone microarchitecture (1 study).

Bone microarchitecture

upin mice1

1 study

  1. miR-21A-5P agomir improves bone microarchitecture in mice.

    “In vivo, treatment with either migrasomes or the miR-21a-5p agomiR significantly improved bone microarchitecture in OVX mice.”

    Animalsovariectomy-induced osteoporosisagomiRbone

    Packages from immature bone-forming cells reduced bone loss in mice

    Journal of translational medicine

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 paper in 12 months
Journal of Translational Medicine

Packages from immature bone-forming cells reduced bone loss in mice

In a mouse experiment, injections of packages released by immature bone-forming cells improved bone structure after ovary removal.In a mouse experiment, injections of packages released by immature bone-forming cells improved bone structure after ovary removal.

Mouse studyBones and joints
Paper

Related